Rubicon Genomics

Rubicon Genomics was founded in 2000 by two University of Michigan faculty members, Dr. John Langmore and Dr. Vladimir Makarov, who wanted to advance the translation of human genetics “laboratory knowledge” into practical medical applications. The founders also decided to maintain the company’s roots in Michigan with a commitment to supporting the Michigan economy. Today, Rubicon Genomics is a privately held company located in Ann Arbor, Michigan. Our innovative products combined with our strategic partnerships have established the company as a leader in pre-analytical amplification technologies. Our core competencies, including enzymology, nucleic acid chemistry, sample processing and manufacturing, have served as engines for innovation, development of intellectual property, and ongoing product development. Our partnership with the academic community and our customers has fueled our engine, resulting in a robust pipeline of future products. Our products "break the sample barriers" for our customers allowing use of less sample from a diverse set of sample sources. Each of our kits is constructed for ease of use, robustness, and speed to results. RGI products are available for research use and can be purchased direct, through our distributors or OEM partners.
Company Growth (employees)
Type
Private
HQ
Ann Arbor, US
Founded
2000
Size (employees)
21 (est)-8%
Rubicon Genomics was founded in 2000 and is headquartered in Ann Arbor, US

Rubicon Genomics Office Locations

Rubicon Genomics has an office in Ann Arbor
Ann Arbor, US (HQ)
4743 Venture Dr

Rubicon Genomics Data and Metrics

Summary Metrics

Founding Date

2000

Total Funding

$5.5 m

Latest funding size

$2 m

Time since last funding

almost 2 years

Investors

Rubicon Genomics's latest funding round in July 2015 was reported to be $2 m. In total, Rubicon Genomics has raised $5.5 m

Rubicon Genomics Online and Social Media Presence

Rubicon Genomics Company Life and Culture

You may also be interested in